Another novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus GD55 exhibits potent anti-tumor efficacy in hepatocellular carcinoma and prostate cancer [7,8]. This evidence concerns the gene GOLM1 and Familial prostate cancer.